Transport Infrastructure Ireland Tii Currently Owns Maintains And Operates An Intelligent Transport System Its Consisting Of Roadside Equipment And Centralised Systems Including The Control Centre Called The Motorway Operations And Control Centre Mo

Deadline: 23 Jul 2026

Ireland

Ref. No.: 18622477

EMD:Ref Document

Bid Value: Ref Document

183 Days Left

At Nm Ptg Section Providing Loading Unloding Facilities Behind Birth No 4 5 At Newmoring Container By Linking 3 Nos New Lines Other Related Works Total Length 472 14 Meter

Deadline: 23 Jan 2026

Bangladesh

Ref. No.: 18574898

EMD:Ref Document

Bid Value: Ref Document

2 Days Left

Completion Of A Non Exclusive Discount Agreement According To Section 130A 8 Sgb V On The Active Ingredient Eltrombopag Atc B02Bx05 For The Period 01 09 2025 31 08 2027 Plus Extension Option 1X12 Months

Deadline: 05 Jul 2028

Germany

Ref. No.: 18546490

EMD:Ref Document

Bid Value: Ref Document

896 Days Left

Completion Of A Non Exclusive Discount Agreement According To Section 130A 8 Sgb V On The Active Ingredient Amifampridine Atc N07Xx05 For The Period 01 09 2025 31 08 2027 Plus Extension Option 1X12 Months

Deadline: 05 Jul 2028

Germany

Ref. No.: 18544139

EMD:Ref Document

Bid Value: Ref Document

896 Days Left

Completion Of A Non Exclusive Discount Agreement According To Section 130A 8 Sgb V On The Active Ingredient Tafluprost Timolol Atc S01Ed70 For The Time 01 09 2025 31 08 2027

Deadline: 05 Jul 2027

Germany

Ref. No.: 18540197

EMD:Ref Document

Bid Value: Ref Document

530 Days Left

Completion Of A Non Exclusive Discount Agreement According To Section 130A 8 Sgb V For The Active Ingredient Naproxen Esomeprazol Atc M01Ae52 F D Z 01 09 2025 31 08 2027 Plus Extension Option 1X12 Months

Deadline: 05 Jul 2028

Germany

Ref. No.: 18540174

EMD:Ref Document

Bid Value: Ref Document

896 Days Left

Completion Of A Non Exclusive Discount Agreement According To Section 130A 8 Sgb V On The Active Ingredient Amifampridine Atc N07Xx05 For The Period 01 09 2025 31 08 2027 Plus Extension Option 1X12 Months

Deadline: 05 Jul 2028

Germany

Ref. No.: 18538698

EMD:Ref Document

Bid Value: Ref Document

896 Days Left

Completion Of A Non Exclusive Discount Agreement According To Section 130A 8 Sgb V For The Active Ingredient Naproxen Esomeprazol Atc M01Ae52 F D Z 01 09 2025 31 08 2027 Plus Extension Option 1X12 Months

Deadline: 05 Jul 2028

Germany

Ref. No.: 18538565

EMD:Ref Document

Bid Value: Ref Document

896 Days Left

Completion Of A Non Exclusive Discount Agreement According To Section 130A 8 Sgb V For The Active Ingredient Abrocitinib Atc D11Ah08 For The Time 01 09 2025 31 08 2027

Deadline: 05 Jul 2027

Germany

Ref. No.: 18537577

EMD:Ref Document

Bid Value: Ref Document

530 Days Left

Completion Of A Non Exclusive Discount Agreement According To Section 130A 8 Sgb V To The Active Ingredient Umeclidinum Atc R03Bb07 For The Period 01 09 2025 31 08 2027

Deadline: 05 Jul 2027

Germany

Ref. No.: 18535921

EMD:Ref Document

Bid Value: Ref Document

530 Days Left

Completion Of A Non Exclusive Discount Agreement According To Section 130A 8 Sgb V On The Active Ingredient Tofacitinib Atc L04Af01 For The Period 01 09 2025 31 08 2027 Plus Extension Option 1X12 Months

Deadline: 05 Jul 2028

Germany

Ref. No.: 18535573

EMD:Ref Document

Bid Value: Ref Document

896 Days Left

Completion Of A Non Exclusive Discount Agreement According To Section 130A 8 Sgb V On The Active Ingredient Axitinib Atc L01Ek01 For The Time 01 09 2025 31 08 2027 Plus Extension Option 1X12 Months

Deadline: 05 Jul 2028

Germany

Ref. No.: 18532003

EMD:Ref Document

Bid Value: Ref Document

896 Days Left

Completion Of A Non Exclusive Discount Agreement According To Section 130A 8 Sgb V On The Active Ingredient Glaceprevir And Pibrentasvir Atc J05Ap57 For The Period 01 09 2025 31 08 2027

Deadline: 05 Jul 2027

Germany

Ref. No.: 18530733

EMD:Ref Document

Bid Value: Ref Document

530 Days Left

Completion Of A Non Exclusive Discount Agreement According To Section 130A 8 Sgb V On The Active Ingredient Ruxolitinib Atc D11Ah09 For The Period 01 09 2025 31 08 2027

Deadline: 05 Jul 2027

Germany

Ref. No.: 18529644

EMD:Ref Document

Bid Value: Ref Document

530 Days Left

Completion Of A Non Exclusive Discount Agreement According To Section 130A 8 Sgb V For The Active Ingredient Abrocitinib Atc D11Ah08 For The Time 01 09 2025 31 08 2027

Deadline: 05 Jul 2027

Germany

Ref. No.: 18528080

EMD:Ref Document

Bid Value: Ref Document

530 Days Left

Discover Tenders by Automatic Meter Readingamr Sector

Filter Your Search

Tenders by Countries

Browse Popular Sectors

Projects by Regions

Funding Agency

Support

CONTACT DETAILS

Discover Tenders by Automatic Meter Readingamr Sector

Filter Your Search

FREE Trial plan for all new users!